Liang V Tang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Venous Thromboembolism

Direct Oral Anticoagulants

Inferior Vena Cava

Top Venues

Journal of hematology & oncology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tingting Liu, Zhi-Peng Cheng, Yu Hu, Liang V Tang
Tofacitinib for elderly onset hemophagocytic lymphohistiocytosis with gene mutations: a case report. MedComm 5 (4) (2024)
Tingting Liu, Zhi-Peng Cheng, Yu Hu, Liang V Tang
Tofacitinib for elderly onset hemophagocytic lymphohistiocytosis with gene mutations: a case report. MedComm 5 (4) (2024)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Correction for Zhang et al., "Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections". mBio (2023)
Yanyi Tao, Jiewen Ma, Yuanzheng Feng, Chenggang Gao, Tingting Wu, Yunqing Xia, Zhipeng Cheng, Yi Zhang, Tingting Liu, Yu Hu, Liang V Tang
Tissue-type plasminogen activator (tPA) homozygous Tyr471His mutation associates with thromboembolic disease. MedComm 4 (5) (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio (2023)
Yi Zhang, Xuan Lu, Liang V Tang, Linghui Xia, Yu Hu
Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections. mBio 14 (1) (2023)
Liang V Tang, Yanyi Tao, Yuanzheng Feng, Jiewen Ma, Wenyi Lin, Yuyang Zhang, Yi Zhang, Tingting Wu, Yaohua Cai, Hui Lu, Jun Wei, Javier Corral, Han Yan
Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice. Science translational medicine 14 (673) (2022)
Liang V Tang, Yu Hu
Hemophagocytic lymphohistiocytosis after COVID-19 vaccination. Journal of hematology & oncology 14 (1) (2021)
Jun-Ying Li, Hong-Fei Wang, Ping Yin, Di Li, Di-Le Wang, Peng Peng, Wei-Hua Wang, Lan Wang, Xiao-Wei Yuan, Jin-Yuan Xie, Fan Zhou, Nian Xiong, Feng Shao, Chun-Xiu Wang, Xiang Tong, Hao Ye, Wen-Jun Wan, Ben-De Liu, Wen-Zhu Li, Qian Li, Liang V Tang, Yu Hu, Gregory Y H Lip, null null
Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study. Journal of thrombosis and haemostasis : JTH 19 (4) (2021)